Research
Print page Print page
Switch language
Clinical Pharmacology, Department of - a part of Copenhagen University Hospital
  1. 2022
  2. E-pub ahead of print

    Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial

    Kårhus, M. L., Brønden, A., Forman, J. L., Haaber, A., Knudsen, E., Langholz, E., Dragsted, L. O., Hansen, S. H., Krakauer, M., Vilsbøll, T., Sonne, D. P. & Knop, F. K., 19 Jul 2022, (E-pub ahead of print) In: The Lancet Gastroenterology and Hepatology.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2021
  4. Published

    Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

    Bronden, A., Nerild, H. H., Nexoe-Larsen, C. C., Hellmann, P. H., Baekdal, M., Gether, I. M., Gillum, M. P., Hartmann, B., Knudsen, L. B., Jacobsen, L. V., Rehfeld, J. F., Holst, J. J., Vilsboll, T., Sonne, D. P. & Knop, F. K., Sep 2021, p. 94-94. 1 p.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  5. Published

    The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1

    Nerild, H. H., Bronden, A., Haddouchi, A. E., Holst, J. J., Sonne, D. P., Vilsboll, T. & Knop, F. K., Sep 2021, p. 217-217. 1 p.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  6. Published

    The Glucagon-Like Peptide-1 Analog, Liraglutide Is a Safe and Effective Treatment of Bile Acid Malabsorption: A Proof of Concept Study

    Karhus, M. L., Bronden, A., Forman, J., Haaber, A., Langholz, E., Vilsboll, T., Sonne, D. P. & Knop, F. K., Jun 2021.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  7. Published

    The Glucose-Lowering Effect of the Bile Acid Sequestrant Sevelamer Is Not Mediated by Glucagon-Like Peptide-1

    Nerild, H. H., Bronden, A., El Haddouchi, A., Holst, J. J., Sonne, D. P., Vilsboll, T. & Knop, F. K., Jun 2021.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  8. Published

    Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption

    Kårhus, M. L., Brønden, A., Lyng Forman, J., Haaber, A., Vilsbøll, T., Sonne, D. P. & Knop, F. K. K., 8 Feb 2021, In: BMJ Open. 11, 2, p. e044711 e044711.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. 2020
  10. Published

    Lower expression of bile acid transporters and fibroblast growth factor 19 in mucosa biopsies from the intestine of patients with type 2 diabetes compared to healthy controls

    Nerild, H. H., El Haddouchi, A., Bronden, A., Jorsal, T., Sonne, D. P., Jelsing, J., Rigbolt, K., Vilsboll, T. & Knop, F. K., Sep 2020, p. S156-S156.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  11. Published

    Lower Expression of Bile Acid Transporters and Fibroblast Growth Factor 19 in Mucosa Biopsies from the Ileocecal Region in Persons with Type 2 Diabetes Compared with Healthy Controls

    Nerild, H. H., Bronden, A., El Haddouchi, A., Jorsal, T., Sonne, D. P., Jelsing, J., Rigbolt, K., Vilsboll, T. & Knop, F. K., Jun 2020.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  12. Published

    Clinical pharmacology of imeglimin for the treatment of type 2 diabetes

    Johansson, K. S., Brønden, A., Knop, F. K. & Christensen, M. B., 23 May 2020, In: Expert Opinion on Pharmacotherapy. 21, 8, p. 871-882 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  13. Published
  14. 2019
  15. Published

    Remission of bile acid malabsorption symptoms following treatment with the glucagon-like peptide 1 receptor agonist liraglutide

    Kårhus, M. L., Brønden, A., Røder, M. E., Leotta, S., Sonne, D. P. & Knop, F. K., 1 Aug 2019, In: Gastroenterology. 157, 2, p. 569-571 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. 2018
  17. Published

    Effects of liraglutide on gallbladder emptying: a randomised, placebo-controlled trial in adults with overweight or obesity

    Nexøe-Larsen, C. C., Sørensen, P. H., Hausner, H., Agersnap, M., Baekdal, M., Brønden, A., Gustafsson, L. N., Sonne, D. P., Vedtofte, L., Vilsbøll, T. & Knop, F. K., Nov 2018, In: Diabetes, Obesity and Metabolism Online. 20, 11, p. 2557-2564 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Preclinical discovery and development of colesevelam for the treatment of type 2 diabetes

    Nerild, H. H., Christensen, M. B., Knop, F. K. & Brønden, A., Oct 2018, In: Expert Opinion on Drug Discovery. 13, 12, p. 1161-1167 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. 2017
  20. Published

    Evidence connecting old, new and neglected glucose-lowering drugs to bile acid-induced GLP-1 secretion: A review

    Kårhus, M. L., Brønden, A., Sonne, D. P., Vilsbøll, T. & Knop, F. K., Sep 2017, In: Diabetes, Obesity and Metabolism. p. 1214-1222 8 p.

    Research output: Contribution to journalReviewResearchpeer-review

  21. 2016
  22. Published

    Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses

    Sonne, D. P., Rohde, U., Christensen, M., Hansen, M., Brønden, A., Toräng, S., Rehfeld, J. F., Holst, J. J., Vilsbøll, T. & Knop, F. K., May 2016, In: Journal of Clinical Endocrinology and Metabolism. 101, 5, p. 2076-83 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. 2015
  24. Published

    Albiglutide for treating type 2 diabetes: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy

    Brønden, A., Naver, S. V., Knop, F. K. & Christensen, M., 2015, In: Expert Opinion on Drug Metabolism & Toxicology. 11, 9, p. 1493-503 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 30986208